Event Details

KemPharm® is a rare disease therapeutics company focused on the discovery, development and commercialization of novel treatments for rare CNS and neurodegenerative diseases, lysosomal storage disorders and related treatment areas.

KemPharm First Quarter 2018 Corporate Update Call

May 10, 2018 at 4:30 PM EDT